Allogene Therapeutics, Inc.
ALLO
Jodie situation report
Allogene Therapeutics, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 19 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 9 directly disclosed connections are confirming.
- ALLO's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if ALLO's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind ALLO
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
PFEPfizer, Inc.partnerMay 13, 2026 ▾
“Research Collaboration and License Agreement with Cellectis In June 2014, Pfizer entered into a Research Collaboration and License Agreement with Cellectis.”
CLLSFiling-linked namepartnerMay 13, 2026 ▾
“Asset Contribution Agreement with Pfizer In April 2018, we entered into an Asset Contribution Agreement (the Pfizer Agreement) with Pfizer pursuant to which we acquired certain assets and assumed certain liabilities from Pfizer, including agreements with Cell…”
Depended on by
ARTVArtiva Biotherapeutics, Inc.competitorMay 8, 2026 ▾
“Our known biopharmaceutical competitors that are developing allogeneic NK, CAR-NK, or CAR-T cell therapies or T-cell engaging bispecific antibodies include, but may not be limited to, the following: Adicet Bio, Inc., Allogene Therapeutics, Inc., Amgen Inc., A…”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 9 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
ALLO is currently a Follower in the organic co-movement group Biotech and Materials. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for ALLO; it is not active in the latest market snapshot.